From Product to Patient-Transfusion and Patient Blood Management

Matthew A Warner; Linda Shore-Lesserson; Carolyn Burns

doi:10.1001/jama.2023.16945

From Product to Patient-Transfusion and Patient Blood Management

JAMA. 2023 Nov 21;330(19):1837-1838. doi: 10.1001/jama.2023.16945.

Authors

Matthew A Warner¹, Linda Shore-Lesserson^{2

3}, Carolyn Burns^{4

5}

Affiliations

¹ Division of Critical Care Medicine, Department of Anesthesiology & Perioperative Medicine, Mayo Clinic, Rochester, Minnesota.
² Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.
³ Department of Anesthesiology, North Shore University Hospital, Manhasset, New York.
⁴ Collaborative Clinical Consulting, LLC, Louisville, Kentucky.
⁵ Society for the Advancement of Patient Blood Management, Mt Royal, New Jersey.

PMID: 37824133
DOI: 10.1001/jama.2023.16945

No abstract available

Plain language summary

This Viewpoint discusses how patient blood management can help curb the demand for blood products and reduce harm by determining who would most benefit from a blood transfusion.

MeSH terms

Blood Transfusion*
Humans
Patient Care Management* / organization & administration